New Delhi, December 14: AstraZeneca Pharma India on Wednesday said Gagandeep Singh Bedi has resigned from the post of managing director. One Shot of Pfizer, AstraZeneca COVID-19 Vaccine Offers 60% Protection Against Coronavirus, Says Study.

The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years with effect from January 1, 2023. AstraZeneca COVID-19 Vaccine Protection May Last a Lifetime, Says Study.

Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)